Cardiac-resynchronization therapy for the prevention of heart-failure events

New England Journal of Medicine

Volumn 361, Issue 14, 2009, Pages 1329-1338

  Moss, Arthur J ^a   Hall, W Jackson ^a   Cannom, David S ^b   Klein, Helmut ^a   Brown, Mary W ^a   Daubert, James P ^c   Estes III, N A Mark ^d   Foster, Elyse ^e   Greenberg, Henry ^f   Higgins, Steven L ^g   Pfeffer, Marc A ^h   Solomon, Scott D ^h   Wilber, David ⁱ   Zareba, Wojciech ^a   Desai, P ^j   Wiggins, S ^j   Greer, G ^j   Beau, S ^j   Curnis, A ^j   Katz, A ^j   Cook, J ^j   McPherson, C ^j   Rozmus, G ^j   Switzer, D ^j   Stone, J ^j   Ludmer, P ^j   Colavita, P ^j   Tomassoni, G ^j   Crevey, B ^j   Nair, G ^j   Saliba, W ^j   Corbisiero, R ^j   Gilliam, F ^j   Hranitzky, P ^j   Rashtian, M ^j   Giudici, M ^j   Thomsen, P ^j   Clyne, C ^j   Pena, E ^j   Lessmeier, T ^j   Schuger, C ^j   Vogt, J ^j   Kacet, S ^j   Almendral, J ^j   Quesada, A ^j   Kautzner, J ^j   Padeletti, L ^j   Delnoy, P ^j   Goel, S ^j   Berger, R ^j   Pitschner, H ^j   Martin, D ^j   Kfoury, A ^j   Klein, S ^j   Levin, V ^j   Schalij, M ^j   Chow, T ^j   Chung, E ^j   Greenberg, Y ^j   Lemke, B ^j   Singh, J ^j   Rea, R ^j   Gold, M ^j   Guttigoli, A ^j   Adler, A ^j   Singer, I ^j   Shinn, T ^j   Guarnieri, T ^j   Casey, C ^j   Naccarelli, G ^j   Gornick, C ^j   Thibault, B ^j   Ackerman, S ^j   Turk, K ^j   Hunter, N ^j   Jentzer, J ^j   Bartlett, T ^j   Glascock, D ^j   Tamirisa, K ^j   Goldberger, J ^j   Coman, J ^j   Sandler, D ^j   Malik, R ^j   Nair, L ^j   O'Neill, P ^j   Sharma, A ^j   Brodine, W ^j   Kargul, W ^j   Porter, M ^j   Merkely, B ^j   Onufer, J ^j   Eldar, M ^j   Gottipaty, V ^j   Pires, L ^j   Wilson, D ^j   Arshad, A ^j   Fischer, A ^j   Mollerus, M ^j   Dixon, M ^j   Clair, W ^j   Wang, P ^j   Cox, M ^j   Viskin, S ^j   Greenspon, A ^j   Thakur, R ^j   Link, M ^j   Goette, A ^j   Duru, F ^j   Parker, J ^j   Stambler, B ^j   Meine, M ^j   Badhwar, N ^j   Olgin, J ^j   Knight, B ^j   Attari, M ^j   Berenbom, L ^j   Shorofsky, S ^j   Pelosi, F ^j   Mounsey, J ^j   Sanders, W ^j   Barrington, W ^j   Huang, D ^j   Saxon, L ^j   DiMarco, J ^j   Merillat, J ^j   Bajaj, R ^j   Margolis, D ^j   Ewald, G ^j   Morgan, J ^j   Finta, B ^j   Haines, D ^j   Oakes, D ^j   Pearson, T ^j   Richeson, F ^j   Pomerantz, R ^j   Goldstein, R ^j   Haigney, M ^j   Krone, R ^j   Dwyer, E ^j   Kukin, M ^j   Lichstein, E ^j   Beck, C ^j   McNitt, S ^j   Zhang, H ^j   Bausch, J ^j   Wang, H ^j   Andrews, M ^j   Barber, D ^j   Buermann, R ^j   Cermak, P ^j   Kremer, K ^j   Moll, J ^j   Oberer, A ^j   Palmmontalbano, L ^j   Perkins, E ^j   Pyykkonen, K ^j   Ramsell, D ^j   more..

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b GOOD SAMARITAN HOSPITAL   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d TUFTS MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^g SCRIPPS MEMORIAL HOSPITAL   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^j NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART DEATH; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE VOLUME; HEART VENTRICLE REMODELING; HUMAN; ISCHEMIC HEART DISEASE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERICARDIAL EFFUSION; PNEUMOTHORAX; PRIORITY JOURNAL; QRS COMPLEX; RANDOMIZED CONTROLLED TRIAL; SURGICAL INFECTION; ARTIFICIAL HEART PACEMAKER; CARDIOVERSION; DISEASE FREE SURVIVAL; HEART PACING; HEART STROKE VOLUME; KAPLAN MEIER METHOD; MIDDLE AGED; MULTICENTER STUDY;

AGED; CARDIAC PACING, ARTIFICIAL; DEFIBRILLATORS, IMPLANTABLE; DISEASE-FREE SURVIVAL; ELECTRIC COUNTERSHOCK; FEMALE; HEART FAILURE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; STROKE VOLUME;

EID: 70349625757     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa0906431     Document Type: Article

References (18)

1. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-237 [Erratum, N Engl J Med 2005;352:2146.]
2. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-1940
3. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883 (Pubitemid 34984635)
4. Goldenberg I, Moss AJ, Hall WJ, et al. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the Multicenter Automatic Defibrillator Implantation Trial II. Circulation 2006;113:2810-2817 (Pubitemid 44305293)
5. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150 (Pubitemid 38637994)
6. Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549 (Pubitemid 40517094)
7. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008; 117(21):e350-e408. [Erratum, Circulation 2009;120(5):e34-e35.]
8. Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 2008;52:1834-1843
9. Moss AJ, Brown MW, Cannom DS, et al. Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT): design and clinical protocol. Ann Noninvasive Electrocardiol 2005;10:Suppl:34-43.
10. Healy B, Campeau L, Gray R, et al. Conflict-of-interest guidelines for a multicenter clinical trial of treatment after coronary-artery bypass-graft surgery. N Engl J Med 1989;320:949-951 (Pubitemid 19101610)
11. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-1463 (Pubitemid 41821197)
12. Wang SK, Tsiatis AA. Approximately optimal one-parameter boundaries for group sequential trials. Biometrics 1987;43:193-199
13. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972;34:187-220.
14. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. 2nd ed. Hoboken, NJ: John Wiley, 2002.
15. Hall WJ, Liu A. Sequential tests and estimates after overrunning based on maximum-likelihood ordering. Biometrika 2002;89:699-707. (Pubitemid 41311975)
16. Skali H, Pfeffer MA, Lubsen J, Solomon SD. Variable impact of combining fatal and nonfatal end points in heart failure trials. Circulation 2006;114:2298-2303 (Pubitemid 44801489)
17. Sharma AD, Rizo-Patron C, Hallstrom AP, et al. Percent right ventricular pacing predicts outcomes in the DAVID trial. Heart Rhythm 2005;2:830-834 (Pubitemid 41030726)
18. Wilkoff BL, Cook JR, Epstein AE, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002;288:3115-3123